Eli Lilly's top dealmaker says don't be surprised to see more M&A that pushes Lilly into new areas
CNBC
Read Full Article at CNBC →Ad Slot — In-Article (728x90)
Eli Lilly's new top dealmaker explains how the company changed its approach to M&A now that it's the most valuable pharmaceutical company in the world.
This is a summary. For the full story, read the original article at CNBC.
Original source: CNBC